Meeting
Abstract Number: 163
Hospital Medicine 2020, Virtual Competition
Background: Low serum concentrations of tetracycline antibiotics may raise concerns on their efficacy in patients with secondary bacteremia, especially in comorbid patients and in those with higher acuity of illness. Omadacycline (OMC), an aminomethylcycline antibiotic, showed non-inferiority to linezolid (LZD) in two acute bacterial skin and skin structure infections (ABSSSI) studies (Omadacycline in Acute Skin […]
Abstract Number: 164
Hospital Medicine 2020, Virtual Competition
Background: The risk for serious infections and poor treatment outcomes is reported to be higher in patients with diabetes compared to the general population. Omadacycline (OMC) is an intravenous (IV) and oral aminomethylcycline antibiotic approved in the US to treat acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) in adults. […]